GSS Investor Presentation - Proposed Merger with MAP
Filed with ASX · · 16 pages · English
Watch Genetic Signatures' latest callGenetic Signatures (ASX:GSS) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Genetic Signatures (ASX:GSS) Q4 2026 Earnings CallGenetic Signatures Ltd. on 6ix
In the deck
Earlier from Genetic Signatures
- Receipt of Section 249D Notice from BCAL Diagnostics
- BDX Holdings of GSS Shares and receipt of Section 249D
- Genetic Signatures and Microba in Merger Discussions
- FY26 Market Update
- GSS responds to the BCAL Diagnostics Announcement
Later from Genetic Signatures
- Quarterly Activities/Appendix 4C Cash Flow Report
- GSS: Response to Media Speculation & BCAL letter to GSS
- Response to Media Speculation & BCAL letter to GSS
- Update on Commercial Terms for Proposed Merger with MAP
- Addendum to Notice of Annual General Meeting
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures